aclidinium bromide | tudorza pressair | anticholinergic | chronic obstructive pulmonary disease | ipratropium, tiotropium | Chapter 36. Pulmonary Pharmacology |
avanafil | stendra | phosphodiesterase 5 inhibitor | erectile dysfunction | sildenafil, tadalafil, vardenafil | Chapter 36. Pulmonary Pharmacology |
axitinib | inlyta | tyrosine kinase inhibitor (VEGFR–1, –2, and –3) | advanced renal cell carcinoma | pazopanib, ponatinib, sunitinib, vandetanib | Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines |
apixaban | eliquis | factor Xa inhibitor | to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation | fondaparinux, rivaroxaban | Chapter 30. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs |
bosutinib† | bosulif | tyrosine kinase inhibitor (Bcr-Abl) | chronic myelogenous leukemia | dasatinib, imatinib, nilotinib, ponatinib | Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines |
cabozantinib† | cometriq | tyrosine kinase inhibitor (multi-family) | progressive, metastatic medullary thyroid cancer | vandetanib | Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines |
carfilzomib | carfilzomib | proteasome inhibitor | multiple myeloma | bortezomib | Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines |
enzalutamide | xtandi | androgen receptor inhibitor | prostate cancer | bicalutamide, flutamide, nilutamide | Chapter 41. Androgens |
icosapent ethyl | vascepa | eicosapentaenoic acid (omega-3 fatty acid) analog | hypertriglyceridemia | omega-3-acid ethyl esters | Chapter 31. Drug Therapy For Hypercholesterolemia and Dyslipidemia |
lucinactant | surfaxin | lung surfactant | respiratory distress syndrome | beractant, calfactant, poractant alfa | Chapter 36. Pulmonary Pharmacology |
pancrelipase | pertzye# | pancreatic enzyme | pancreatic insufficiency | creon, pancreaze, zenpep | Chapter 46. Treatment of Disorders of Bowel Motility and Water Flux; Anti-Emetics; Agents Used in Biliary and Pancreatic Disease |
| ultresa# | | | | |
| viokace# | | | | |
pasireotide diaspartate† | signifor | somatostatin analog | Cushing's disease | lanreotide, octreotide | Chapter 38. Introduction To Endocrinology: The Hypothalamic-Pituitary Axis |
peginesatide acetate | omontys | erythropoiesis-stimulating agent | anemia due to chronic kidney disease | darbepoetin alfa, epoetin alfa | Chapter 37. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins |
pertuzumab | perjeta | monoclonal antibody against HER2/neu receptor | metastatic breast cancer | trastuzumab | Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines |
ponatinib† | iclusig | tyrosine kinase inhibitor (multi-family) | chronic myeloid leukemia | dasatinib, imatinib, nilotinib, ponatinib, vandetanib | Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines |
regorafenib | stivarga | tyrosine kinase inhibitor (multi-family) | metastatic colorectal cancer | sorafenib | Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines |
sodium picosulfate, magnesium oxide, citric acid | prepopik | laxative | colon cleansing prior to colonoscopy | sodium phosphates; magnesium citrate | Chapter 46. Treatment of Disorders of Bowel Motility and Water Flux; Anti-Emetics; Agents Used in Biliary and Pancreatic Disease |
tafluprost | zioptan | prostaglandin F2 agonist | elevated intraocular pressure | bimatoprost, latanoprost, travoprost | Chapter 64. Ocular Pharmacology |
taliglucerase alfa† | elelyso | beta-glucocerebrosidase analog | Gaucher disease | imiglucerase, velaglucerase | Chapter 44. Agents Affecting Mineral Ion Homeostasis and Bone Turnover |
tbo-filgrastim | tbo-filgrastim | granulocyte colony stimulating factor (G-CSF) | neutropenia | filgrastim, pegfilgrastim | Chapter 37. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins |
teriflunomide | aubagio | pyrimidine synthesis inhibitor | multiple sclerosis | leflunomide | Chapter 35. Immunosuppressants, Tolerogens, and Immunostimulants |
tofacitinib (CP-690550) | xeljanz | janus kinase inhibitor | rheumatoid arthritis | ruxolitinib | Chapter 35. Immunosuppressants, Tolerogens, And Immunostimulants |
ziv-aflibercept | zaltrap | vascular endothelial growth factor antagonist | metastatic colorectal cancer | aflibercept | Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines |